BioSpace News Archive

The sale of Xiidra to Novartis and TachoSil to Ethicon is part of Takeda’s strategy to pare down debt from its $62 billion acquisition of Shire.

The inclusion of the list price is part of an effort from the administration to lower the cost of prescription drugs. The industry’s lobbying arm believes the inclusion will be confusing to patients.

Avanos Medical, Inc. announced that it commenced a cash tender offer to purchase up to $129,840,000 in aggregate purchase price of its outstanding 6.250 percent Senior Unsecured Notes due October 15, 2022.

ICON plc announced the release of its web based patient engagement platform, to provide patients with study specific information and connectivity with the nearest investigative site.

A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease.

Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry today announced the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.

Sareum Holdings plc (AIM: SAR), the specialist small molecule drug development business, notes that Sierra Oncology (”Sierra”), the licence holder advancing clinical cancer candidate SRA737, has announced its results for the first quarter 2019.

“This first quarter of 2019, we were busy ensuring that the recruitment efforts for our pivotal phase 3 study NefIgArd remain on track, focusing on site initiation visits and supporting our CRO in their work to ensure that all sites are brought online on a timely manner.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that long-term follow up data from a completed Phase 1/2 study evaluating EB-101 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) will be presented at the 77th Annual Meeting of the Society for Investigative Dermatology

Ideagen, the UK-based, global software firm, has unveiled a new mental health awareness and advice project as it looks to become a global destination employer.